Industry / Italy
Chiesi's Inhaler Approaches Market
May 2006 | Project NewsUK firm Bespak is ramping up production of Italian company Chiesi Farmaceutica's new dry powder inhaler (DPI) - Next - ahead of pivotal, late-stage clinical trials of the device for the treatment of asthma and chronic obstructive pulmonary disorder.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
